| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 10, 2021 | Dec 14, 2021 | Alector, Inc. | COO | Sell | 5.0 | -150,000 | -25.85% | ✓ | $3.2M |
| Dec 8, 2021 | Dec 10, 2021 | Alector, Inc. | COO | Sell | 10.0 | -150,000 | -24.94% | ✓ | $3.4M |
| Feb 20, 2019 | Feb 22, 2019 | Theravance Biopharma, Inc. | SVP, Corp Dev & Strategy | Sell | 22.5 | -5,763 | -5.60% | ✗ | $155.6K |
| Feb 20, 2018 | Feb 22, 2018 | Theravance Biopharma, Inc. | SVP, Corp Dev & Strategy | Sell | 20.0 | -8,770 | -7.97% | ✗ | $255.1K |